Jay R. Luly
2021
Compensation breakdown
| Non-Equity Incentive Plan | $518,822 |
|---|---|
| Option Awards | $2,283,872 |
| Salary | $693,188 |
| Stock Awards | $1,778,616 |
| Other | $19,211 |
| Total | $5,293,709 |
Luly received $2.3M in option awards, accounting for 43% of the total pay in 2021.
Luly also received $518.8K in non-equity incentive plan, $693.2K in salary, $1.8M in stock awards and $19.2K in other compensation.
Rankings
In 2021, Jay R. Luly's compensation ranked 2,444th out of 12,415 executives tracked by ExecPay. In other words, Luly earned more than 80.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,444 out of 12,415 | 80th |
Division Manufacturing | 968 out of 5,508 | 82nd |
Major group Chemicals And Allied Products | 369 out of 2,378 | 85th |
Industry group Drugs | 321 out of 2,099 | 85th |
Industry Pharmaceutical Preparations | 212 out of 1,549 | 86th |
Pay ratio
| Jay R. Luly's Pay | $5,293,709 |
|---|---|
| Median Employee's Pay | $230,731 |
| Pay Ratio | 23to 1 |
In 2021, the annual total compensation of Jay R. Luly was $5,293,709.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $230,731.
The ratio of Jay R. Luly's pay to the pay of median employee was therefore 23 to one.
Luly's colleagues
We found five more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2021.
2021
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
2021
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
2021
Yat Or
Enanta Pharmaceuticals
Chief Scientific Officer
2021
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
2021
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019